SIINFEKL

SIINFEKL, commonly referred to as OVA8, is an eight-amino acid peptide derived from chicken egg ovalbumin that serves as the immunodominant MHC class I-restricted epitope in C57BL/6 mice. It is specifically presented by the H-2Kb molecule to CD8+ T cells. Due to its well-characterized interaction with the OT-I T-cell receptor, SIINFEKL is a cornerstone of experimental immunology, used extensively to study antigen presentation, T-cell activation, and vaccine delivery systems. In recent therapeutic research, it has been utilized as a model antigen in programmable nanovaccine platforms, such as peptide nucleic acid (PNA)-based vaccines, to induce targeted anti-tumor immune responses and evaluate the efficacy of novel immunotherapy delivery vehicles in syngeneic melanoma models.

Other names

Ovalbumin peptideH-2Kb-restricted ovalbumin epitopeH2Kb-restricted ovalbumin epitopeH 2Kb-restricted ovalbumin epitopeOvalbumin (257-264)